Brint Family Translational Research Award
Funds preclinical translational partnerships for companies advancing Friedreich ataxia therapies.
The Brint Family Translational Research Award (BFTRP), formerly known as TRAP, is administered by the Foundation Fighting Blindness — a US 501(c)(3) public charity established in 1971 that has raised nearly $1 billion toward research into inherited retinal diseases and macular degeneration. BFTRP specifically targets preclinical translational research for inherited retinal degenerations (IRD) and …
Funds preclinical translational research accelerating novel therapies — including small molecules, gene delivery, and restorative cell/tissue approaches — toward clinical application for inherited retinal degenerations and dry AMD.
Sign up free to see the funding breakdown
Sign up free to see the industries in scope
Sign up free to see the full eligibility
Sign up free to see how to apply
Sign up free to see what you submit
Sign up free to see the timeline